These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 27174644)

  • 1. CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves.
    Martínez-Muriana A; Mancuso R; Francos-Quijorna I; Olmos-Alonso A; Osta R; Perry VH; Navarro X; Gomez-Nicola D; López-Vales R
    Sci Rep; 2016 May; 6():25663. PubMed ID: 27174644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration.
    Neal ML; Fleming SM; Budge KM; Boyle AM; Kim C; Alam G; Beier EE; Wu LJ; Richardson JR
    FASEB J; 2020 Jan; 34(1):1679-1694. PubMed ID: 31914683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
    Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tweak regulates astrogliosis, microgliosis and skeletal muscle atrophy in a mouse model of amyotrophic lateral sclerosis.
    Bowerman M; Salsac C; Coque E; Eiselt É; Deschaumes RG; Brodovitch A; Burkly LC; Scamps F; Raoul C
    Hum Mol Genet; 2015 Jun; 24(12):3440-56. PubMed ID: 25765661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.
    Olmos-Alonso A; Schetters ST; Sri S; Askew K; Mancuso R; Vargas-Caballero M; Holscher C; Perry VH; Gomez-Nicola D
    Brain; 2016 Mar; 139(Pt 3):891-907. PubMed ID: 26747862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting microglia proliferation after spinal cord injury improves recovery in mice and nonhuman primates.
    Poulen G; Aloy E; Bringuier CM; Mestre-Francés N; Artus EVF; Cardoso M; Perez JC; Goze-Bac C; Boukhaddaoui H; Lonjon N; Gerber YN; Perrin FE
    Theranostics; 2021; 11(18):8640-8659. PubMed ID: 34522204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of methylene blue on microglia-induced inflammation and motor neuron degeneration in the SOD1(G93A) model for ALS.
    Dibaj P; Zschüntzsch J; Steffens H; Scheffel J; Göricke B; Weishaupt JH; Le Meur K; Kirchhoff F; Hanisch UK; Schomburg ED; Neusch C
    PLoS One; 2012; 7(8):e43963. PubMed ID: 22952827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
    Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
    Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.
    Gowing G; Philips T; Van Wijmeersch B; Audet JN; Dewil M; Van Den Bosch L; Billiau AD; Robberecht W; Julien JP
    J Neurosci; 2008 Oct; 28(41):10234-44. PubMed ID: 18842883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
    Apolloni S; Fabbrizio P; Amadio S; Volonté C
    J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis.
    Beers DR; Henkel JS; Xiao Q; Zhao W; Wang J; Yen AA; Siklos L; McKercher SR; Appel SH
    Proc Natl Acad Sci U S A; 2006 Oct; 103(43):16021-6. PubMed ID: 17043238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1
    MacLean M; Juranek J; Cuddapah S; López-Díez R; Ruiz HH; Hu J; Frye L; Li H; Gugger PF; Schmidt AM
    J Neuroinflammation; 2021 Jun; 18(1):139. PubMed ID: 34130712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment With the CSF1R Antagonist GW2580, Sensitizes Microglia to Reactive Oxygen Species.
    Soto-Diaz K; Vailati-Riboni M; Louie AY; McKim DB; Gaskins HR; Johnson RW; Steelman AJ
    Front Immunol; 2021; 12():734349. PubMed ID: 34899694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
    Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
    J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of Receptor for Advanced Glycation End Product (RAGE) Reduces Inflammation and Extends Survival in the hSOD1
    Lee JD; McDonald TS; Fung JNT; Woodruff TM
    Mol Neurobiol; 2020 Oct; 57(10):4143-4155. PubMed ID: 32676989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H63D HFE genotype accelerates disease progression in animal models of amyotrophic lateral sclerosis.
    Nandar W; Neely EB; Simmons Z; Connor JR
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2413-26. PubMed ID: 25283820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Ringer C; Büning LS; Schäfer MK; Eiden LE; Weihe E; Schütz B
    Neurobiol Dis; 2013 Jun; 54():32-42. PubMed ID: 23466699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.